Terapêutica da escabiose com sulfeto de selênio a 2,5%
Authors: Minelli Lorivaldo 
Published: March 2016

<!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:HyphenationZone>21</w:HyphenationZone> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> </w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" LatentStyleCount="156"> </w:LatentStyles> </xml><![endif]--><!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Tabela normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;} </style> <![endif]--> <p class="MsoNormal" style="text-align: justify;"><span style="font-size: 8pt; font-family: Verdana; color: black;">Efeito terapêutico do sulfeto de selênio em suspensão a </span><span style="font-size: 8pt; font-family: Verdana; color: black;">2,5% </span><span style="font-size: 8pt; font-family: Verdana; color: black;">na escabiose. Apôs o esquema previsto, </span><span style="font-size: 8pt; font-family: Verdana; color: black;">verificam-se </span><span style="font-size: 8pt; font-family: Verdana; color: black;">os seguintes resultados: curados </span><span style="font-size: 8pt; font-family: Verdana; color: black;">22 </span><span style="font-size: 8pt; font-family: Verdana; color: black;">casos </span><span style="font-size: 8pt; font-family: Verdana; color: black;">(73,33%); </span><span style="font-size: 8pt; font-family: Verdana; color: black;">melhorados </span><span style="font-size: 8pt; font-family: Verdana; color: black;">5 </span><span style="font-size: 8pt; font-family: Verdana; color: black;">casos </span><span style="font-size: 8pt; font-family: Verdana; color: black;">(16,66%); </span><span style="font-size: 8pt; font-family: Verdana; color: black;">inalterados </span><span style="font-size: 8pt; font-family: Verdana; color: black;">3 </span><span style="font-size: 8pt; font-family: Verdana; color: black;">casos </span><span style="font-size: 8pt; font-family: Verdana; color: black;">(10,00%) </span><span style="font-size: 8pt; font-family: Verdana; color: black;">e nenhum caso piorado, num total de </span><span style="font-size: 8pt; font-family: Verdana; color: black;">30 </span><span style="font-size: 8pt; font-family: Verdana; color: black;">pacientes estudados. </span><span style="font-size: 8pt; font-family: Verdana; color: black;">Concluiu-se </span><span style="font-size: 8pt; font-family: Verdana; color: black;">pela eficácia terapêutica do produto na patologia mencionada.</span></p>